SUBSCRIBE
SUBSCRIBE
News   Policy

EU Panel Blocks Merck KGaA’s (JOBS) Erbitux in Lung Cancer

November 20, 2009 | 
1 min read

Bookmark and Share

Reuters -- An influential European expert panel on drug approvals again rejected outright Merck KGaA’s cancer drug Erbitux for use against lung cancer, the company said on Thursday.

Regulatory
MORE ON THIS TOPIC
South side and Dome of the US Capitol in Washington DC, United States
Government
RFK Jr. Passes First Hurdle as Nomination Moves to Full Senate Vote
February 4, 2025
 · 
3 min read
 · 
Tristan Manalac
Weigh scales on pink background, top view with space for text. Overweight concept
Obesity
UK Pharmacies Regulator Wants Tighter Checks on Weight Loss Injections
February 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Government
Trump’s Tariffs Threaten Big Pharma With Higher Costs and Slimmer Margins
February 3, 2025
 · 
3 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: GSK, Indivior, SpringWorks, More
February 3, 2025
 · 
5 min read
 · 
Tristan Manalac